Form 4: Kronos Bio Director Elena Ridloff Reports Stock Option Grant and Share Acquisition
SEC Form 4 Filing
Director Elena Ridloff reported the acquisition of stock options and common stock in Kronos Bio, Inc. on June 25, 2024.
Summary
- On June 25, 2024, Elena Ridloff, a director of Kronos Bio, Inc., reported transactions involving the company's securities.
- Ridloff acquired 17,000 stock options with an exercise price of $0.95, exercisable starting June 25, 2024, and expiring on June 24, 2034.
- These options vest upon the earlier of the one-year anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders.
- Ridloff also acquired 11,333 shares of common stock at $0 and disposed of 25,296 shares.
- Following these transactions, Ridloff directly owns 17,000 derivative securities and 25,296 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The acquisition of options is mildly positive, while the disposal of shares is mildly negative.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposal of 25,296 shares of common stock by a director could be seen as a negative sign.
Risks
- The vesting of the stock options is contingent on the director's continued service or the occurrence of the next annual meeting, which introduces some uncertainty.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of stock options is tied to future events (one-year anniversary or next annual meeting).
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's sentiment about the company's prospects.
Stakeholder Impact
- Shareholders may interpret the director's transactions as a signal of confidence or lack thereof in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of stock option grant and share acquisition/disposal. |
| 06/24/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.